Rapid in vitro screening of drug-metal ion interactions

Toxicology Mechanisms and Methods

Volumn 17, Issue 9, 2007, Pages 559-565

  Sridevi, N ^a   Yusuff, K K Mohammed ^a  

^a Department of Physics   (India)

Author keywords

Drug Interactions; In Vitro Chemical Studies; Levothyroxine; Metal Ions; Ranitidine

Indexed keywords

CALCIUM; CHROMIUM; COPPER; IRON; LEVOTHYROXINE; LEVOTHYROXINE SODIUM; MAGNESIUM; MANGANESE; METAL ION; MOLYBDENUM; RANITIDINE; ZINC;

ARTICLE; CONTROLLED STUDY; DRUG SCREENING; FEASIBILITY STUDY; HUMAN; HUMAN TISSUE; IN VITRO STUDY; PH; PRIORITY JOURNAL; SPECTROPHOTOMETRY; SUPPLEMENTATION;

EID: 36749063580     PISSN: 15376516     EISSN: 15376524     Source Type: Journal    
DOI: 10.1080/15376510701380653     Document Type: Article

References (35)

1. 2-receptor antagonists. Med. Toxicol. Adverse Drug Exp. 3(6):430-448.
2. 2-receptor antagonists. Scand. J. Gastroenterol. Suppl. 206:14-19.
3. Beard, J., Borel, M., and Peterson, F. J. 1997. Changes in iron status during weight loss with very-low-energy diets. Am. J. Clin. Nutr. 66(1):104-110.
4. Beard, J. L., Borel, M. J., and Derr, J. 1990. Impaired thermoregulation and thyroid function in iron-deficiency anemia. Am. J. Clin. Nutr. 52(5):813-819.
5. Beers, M. H. 2000. The Merck Manual of Geriatrics., Merck & Co., Inc., New Jersey. http://www.merck.com/mrkshared/mmg/home.jsp.
6. Beers, M. H. 2005. Clinical pharmacology. In The Merck Manual of Diagnosis and Therapy, Merck & Co. Inc., White house Station, New Jersey. http://www.merck.com/mrk.shared/mmanual/section22/chapter299/299a.jsp.
7. Campbell, N. R., Kara, M., Hasinoff, B. B., Haddara, W. M., and McKay, D. W. 1992. Norfloxacin interaction with antacids and minerals. Br. J. Clin. Pharmacol. 33(1):115-116.
8. Campbell, N. R. C., Hasinoff, B. B., Stalts, H., Rao, B., and Wong, N. C. W. 1992. Ferrous sulfate reduces levothyroxine efficacy in patients with hypothyroidism. Ann. Intern. Med. 117(12):1010-1013.
9. Carr, R. E., and Henkind, P. 1962. Ocular manifestations of ethambutol. Arch. Ophthalmol. 67:566-571.
10. Chau, L. 2004. Drug-associated nutritional problems in older persons. Rev. Clin. Gerontol. 13:183-193.
11. Citron, K. M., and Thomas, G. O. 1986. Ocular toxicity from ethambutol (editorial). Thorax 41:737-739.
12. Cole, A., May, P. M., and Williams, D. R. 1981. Metal binding by pharmaceuticals. Part 1. Copper(II) and zinc(II) interactions following ethambutol administration. Inflamm. Res. 11(3):296-305.
13. Esipenko, B. E., and Marsakova, N. V. 1990. The effect of copper on the metabolism of iodine, carbohydrates and proteins in rats. Fiziol. Zh. 36(2):35-43.http://www.health2us.com/zn cu.htm.
14. U.S. Food and Drug Administration. 2002. The FDA Drug Approval Process. http://idid.essortment.com/fdadrugapprova rrgy.htm
15. Galla, J. H. 2000. Metabolic alkalosis. J. Am. Soc. Nephrol. 11:369-375.
16. Geraldes, C. F. G. C., Gil, V. M. S., Teixeira, M. H. S. F., and Teixeira, F. 1984. NMR studies of cimetidine and ranitidine in solution: acid-base equilibria and effects of antacids. Congr. AMPERE Magn. Reson. Relat. Phenom. Proc. 22:392-393.CA.102:137713.
17. Gringauz, A. 1997. Introduction to Medicinal Chemistry - How Drugs Act and Why, Wiley-VCH, New York.
18. Grossman, L. I., and Brickman, B. M. 1937. Some observations on the pH of saliva. J. Dent. Res. 16(5):409-416.
19. Hoffken, G., Borner, K., Glatzel, P. D., Koeppe, P., and Lode, H. 1985. Reduced enteral absorption of ciprofloxacin in the presence of antacids. Eur. J. Clin. Microbiol. 4(3):345.
20. Kralik, A., Kirchgessner, M., and Eder, K. Z. 1996. Concentrations of thyroid hormones in serum and activity of hepatic 5′ monodeiodinase in copper-deficient rats. Ernahrungswiss 35(3):288-291.http://www.health2us. com/zn cu.htm.
21. Leedman, P. J., Stein, A. R., Chin, W. W., and Rogers, J. T. 1996. Thyroid hormone modulates the interaction between iron regulatory proteins and the ferritin mRNA iron-responsive element. J. Biol. Chem. 271(20):12017-12023.
22. Leibold, J. E. 1966. The ocular toxicity of ethambutol and its relation to dose. Ann. N. Y. Acad. Sci. 135:904-909.
23. Lomaestro, B. M., and Bailie, G. R. 1993. Effect of multiple staggered doses of calcium on the bioavailability of ciprofloxacin. Ann. Pharmacother. 27(11):1325-1328.
24. Mizuno, S., Demura, Y., Ameshima, S., Okamura, S., Miyamori, I., and Ishizaki, T. 2002. Alkalosis stimulates endothelial nitric oxide synthase in cultured human pulmonary arterial endothelial cells. Am. J. Physiol. Lung Cell Mol. Physiol. 283:L113-L119.
25. National Institutes of Health. 2002. Resource information-understanding clinical trials. http://www.clinicaltrials.gov/.
26. Oliver, J. W. 1975. Interrelationships between athyroetic and copper-deficient states in rats. Am. J. Vet. Res. 36(11):1649-1653.http:/ /www.health2us.com/zn cu.htm.
27. Shakir, K. M., Chute, J. P., Aprill, B. S., and Lazarus, A. A. 1997. Ferrous sulfate-induced increase in requirement for levothyroxine in a patient with primary hypothyroidism. South Med. J. 90(6):637-639.
28. Shargel, L. 1990. Pharmacy Review, John Wiley & Sons, New York.
29. Shvartsburg, A. A., and Wilkes, J. G. 2002. Fragmentation chemistry of DMSO complexes of metal dications. J. Phys. Chem. A. 106(18):4543-4551.
30. Solecki, T. J., Aviv, A., and Bogden, J. D. 1984. Effect of a chelating drug on balance and tissue distribution of four essential metals. Toxicology 31(3-4):207-216.
31. Sturniolo, G. C., Montino, M. C., Rossetto, L., Martin, A., D'Inca, R., D'Odorico, A., and Naccarato, R. 1991. Inhibition of gastric acid secretion reduces zinc absorption in man. J. Am. Coll. Nutr. 10(4):372-375.
32. van de Waterbeemd, H., Lennernäs, H., Matuschek, P. A., Hendriks, W., McGhie, T., and Reynolds, G. 2003. Drug Bioavailability: Estimation of Solubility, Permeability, Absorption and Bioavailability, John Wiley & Sons, New York.
33. van Hecken, A. M., Tjandramaga, T. B., Mullie, A., Verbesselt, R., and de Schepper, P. J. 1982. Ranitidine: single dose pharmacokinetics and absolute bioavailability in man. Br. J. Clin. Pharmacol. 14:195-200.
34. Weismann, K. 1986. Chelating drugs and zinc. Dan. Med. Bull. 33(4):208-211.
35. Yang, Y. F., Ohashi, H., and Walfish, P. G. 1990. In vivo expression of rat liver c-erbA beta thyroid hormone receptor in yeast (Saccharomyces cerevisiae). Biochem. Biophys. Res. Commun. 171(1):138-142.